Disclosures for "Intrajejunal Levodopa Infusion for Parkinson's Disease over 11 years: A Canadian Experience")
-
Dr. VEKHANDE has nothing to disclose.
-
Dr. Hamed has nothing to disclose.
-
Ms. Tremain has nothing to disclose.
-
Mrs. Mah has nothing to disclose.
-
Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
-
-
Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.